SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-001820
Filing Date
2023-02-06
Accepted
2023-02-06 06:31:41
Documents
14
Period of Report
2023-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20230206.htm   iXBRL 8-K 55368
2 EX-99.1 idxx-ex99_1.htm EX-99.1 1106579
3 GRAPHIC idxx-ex99_1i0.jpg GRAPHIC 14845
  Complete submission text file 0000950170-23-001820.txt   1340054

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20230206_lab.xml EX-101.LAB 12806
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20230206_pre.xml EX-101.PRE 9447
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20230206.xsd EX-101.SCH 2460
8 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20230206_htm.xml XML 4522
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

IRS No.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 23588324
SIC: 2835 In Vitro & In Vivo Diagnostic Substances